Skip to main content

Table 2 Univariate analysis of factors affecting survival and further brain control after recurrence in the brain after therapeutic or prophylactic irradiation

From: Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis

Characteristics

Survival after Brain Failure

Brain Control after Brain Failure

Hazard Ratio (95% CI)

P Value

Hazard Ratio (95% CI)

P Value

Age at brain recurrence, years

 < 63

1.00

0.757

1.00

0.633

 ≥63

0.931 (0.590–1.468)

 

0.881 (0.526–1.478)

 

ECOG performance status score at brain recurrence

 0–2

1.00

< 0.001

1.00

0.007

 ≥3

4.66 (2.310–9.403)

 

2.776 (1.318–5.849)

 

Sex

 Male

1.00

0.951

1.00

0.361

 Female

0.985 (0.615–1.580)

 

1.285 (0.751–2.199)

 

Ethnicity

 White

1.00

0.373

1.00

0.801

 Non-white

0.762 (0.418–1.386)

 

0.921 (0.485–1.748)

 

Initial disease stage

 Limited

1.00

0.955

1.00

0.129

 Extensive

1.015 (0.605–1.703)

 

1.601 (0.872–2.940)

 

Brain metastases at initial diagnosis

 No

1.00

0.656

1.00

0.519

 Yes

1.112 (0.698–1.771)

 

1.19 (0.701–2.020)

 

No. of brain lesions at initial diagnosis

 ≤4

1.00

0.906

1.00

0.624

 > 4

0.963 (0.518–1.793)

 

1.179 (0.610–2.278)

 

Intent of first brain irradiation

 Prophylactic

1.00

0.910

1.00

0.853

 Therapeutic

0.973 (0.606–1.564)

 

1.051 (0.621–1.778)

 

≥4 chemo cycles before brain recurrence

 No

1.00

0.003

1.00

0.882

 Yes

0.236 (0.091–0.614)

 

0.897 (0.215–3.752)

 

Thoracic radiation therapy dose, Gy

 < 45

1.00

0.487

1.00

0.774

 ≥45

0.844 (0.524–1.361)

 

0.923 (0.532–1.600)

 

No. of brain lesions at brain recurrence

 ≤4

1.00

0.060

1.00

0.033

 > 4

1.552 (0.981–2.454)

 

1.792 (1.049–3.063)

 

Symptoms from brain metastases at brain recurrence

 No

1.00

0.003

1.00

0.043

 Yes

2.041 (1.265–3.294)

 

1.718 (1.018–2.902)

 

Extracranial disease at brain recurrence

 Controlled

1.00

< 0.001

1.00

0.012

 Uncontrolled

2.683 (1.603–4.490)

 

2.084 (1.177–3.689)

 

Chemotherapy after brain recurrence

 No

1.00

< 0.001

1.00

0.085

 Yes

0.406 (0.248–0.663)

 

0.62 (0.360–1.069)

 

WBI or G-knife for brain recurrence

 No

1.00

0.018

1.00

0.009

 Yes

0.576 (0.365–0.908)

 

0.494 (0.290–0.842)

 

Time from the end of first brain irradiation to brain recurrence, mo

 < 6

1.00

0.034

1.00

0.332

 ≥6

0.608 (0.384–0.963)

 

0.77 (0.460–1.291)

 
  1. Abbreviations: ECOG Eastern Cooperative Oncology Group, WBI whole-brain irradiation, G-knife Gamma knife therapy